Full Name | Diana Smith |
---|---|
Gender | Female |
Speciality | Counselor |
Location | 201 22nd St, Ashland, Kentucky |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427156439 | NPI | - | NPPES |
30610026 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Diana Smith, Po Box 790, Ashland, KY 41105-0790 Ph: (606) 329-8588 | Diana Smith, 201 22nd St, Ashland, KY 41101-7803 Ph: (606) 324-1141 |
News Archive
A study to be published in the latest issue of The Cochrane Library and led by researchers at the University of Edinburgh and supported by colleagues at the Peninsula Dental School, the University of Ottawa and UCL Eastman Dental Institute, suggests that the treatment of serious gum (periodontal) disease in diabetics with Type 2 diabetes may lower their blood sugar levels.
eGlobalTech announced today that it has been awarded a prime contract with the Health Resources and Services Administration to support an enterprise-wide Call Center Study.
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that it has received notification from the US Food and Drug Administration (FDA) that the Agency is currently drafting a response to the Company relating to the Investigational New Drug (IND) Application it filed in November seeking clearance to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).
A new process for transforming discarded human fat into a soft-tissue substitute for use in reconstructive surgery is laying the groundwork for creating an Ontario-based regenerative medicine initiative focused on developing products for reconstructive and cosmetic surgery.
ChemDiv, Inc. announced the expansion of its drug discovery collaboration with Eli Lilly through 2010. Under the terms of the agreement, the partners will identify and develop leads for an additional therapeutic target using ChemDiv's small molecule resources (the industry's largest commercial collection) and Discovery outSourceā¢ drug discovery and development platforms.
› Verified 2 days ago
Brandi Dunn, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3701 Landsdowne Dr, Ashland, KY 41102 Phone: 606-324-3005 Fax: 606-329-1530 | |
Kenneth Kennedy, Counselor Medicare: Not Enrolled in Medicare Practice Location: 201 22nd St, Ashland, KY 41101 Phone: 606-324-1141 | |
Ashley Hamm, MHA INTERN Counselor Medicare: Not Enrolled in Medicare Practice Location: 3701 Landsdowne Dr, Ashland, KY 41102 Phone: 606-324-3005 Fax: 606-329-1530 | |
Melissa Fannin, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3701 Lansdowne Dr, Ashland, KY 41102 Phone: 606-324-3005 Fax: 606-329-1530 | |
Cynthia Lynn Barker, L.P.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 10730 Midland Trail Rd, Ashland, KY 41102 Phone: 606-928-0150 | |
Michelle Horton, PSS Counselor Medicare: Not Enrolled in Medicare Practice Location: 201 22nd St, Ashland, KY 41101 Phone: 606-324-1141 Fax: 606-325-2525 | |
Brittany Winters, LPCA Counselor Medicare: Not Enrolled in Medicare Practice Location: 3701 Landsdowne Dr, Ashland, KY 41102 Phone: 606-324-3005 Fax: 606-329-8850 |